新たな遺伝的要因が神経発達障害の原因と特定(Landmark Study Identifies New Genetic Cause of Neurodevelopmental Disorders)

ad

2025-04-10 マウントサイナイ医療システム(MSHS)

マウントサイナイ医科大学の研究チームは、神経発達障害の新たな遺伝的原因として、U2小核RNA(snRNA)の変異を特定しました。この変異は、以前に発見されたRNU4-2遺伝子の変異によるReNU症候群に次いで、snRNAの変異が神経発達障害を引き起こす2例目の報告となります。U2 snRNAは、遺伝子スプライシングにおいて重要な役割を果たしており、その変異はmRNAの処理異常を引き起こし、発達遅延や言語障害、てんかんなどの症状をもたらすことが示されています。この発見は、非コードRNAの変異が疾患の原因となる可能性を示すものであり、診断や治療の新たな道を開くと期待されています。

<関連情報>

小核RNA遺伝子RNU2-2の変異がてんかんを伴う重篤な神経発達障害を引き起こす Mutations in the small nuclear RNA gene RNU2-2 cause a severe neurodevelopmental disorder with prominent epilepsy

Daniel Greene,Koenraad De Wispelaere,Jon Lees,Marta Codina-Solà,Brynjar O. Jensson,Emma Hales,Andrea Katrinecz,Esther Nieto Molina,Sonia Pascoal,Rolph Pfundt,Rachel Schot,Marta Sevilla Porras,Frank Sleutels,Irene Valenzuela,Robin Wijngaard,Ignacio Arroyo Carrera,Giles Atton,Didac Casas-Alba,Deirdre Donnelly,Anna Duat Rodríguez,Bárbara Fernández Garoz,Nicola Foulds,Deyanira García-Navas Núñez,Elena González Alguacil,… Ernest Turro
Nature Genetics  Published:10 April 2025
DOI:https://doi.org/10.1038/s41588-025-02159-5

新たな遺伝的要因が神経発達障害の原因と特定(Landmark Study Identifies New Genetic Cause of Neurodevelopmental Disorders)

Abstract

The major spliceosome includes five small nuclear RNA (snRNAs), U1, U2, U4, U5 and U6, each of which is encoded by multiple genes. We recently showed that mutations in RNU4-2, the gene that encodes the U4-2 snRNA, cause one of the most prevalent monogenic neurodevelopmental disorders. Here, we report that recurrent germline mutations in RNU2-2 (previously known as pseudogene RNU2-2P), a 191-bp gene that encodes the U2-2 snRNA, are responsible for a related disorder. By genetic association, we identified recurrent de novo single-nucleotide mutations at nucleotide positions 4 and 35 of RNU2-2 in nine cases. We replicated this finding in 16 additional cases, bringing the total to 25. We estimate that RNU2-2 syndrome has a prevalence of ~20% that of RNU4-2 syndrome. The disorder is characterized by intellectual disability, autistic behavior, microcephaly, hypotonia, epilepsy and hyperventilation. All cases display a severe and complex seizure phenotype. We found that U2-2 and canonical U2-1 were similarly expressed in blood. Despite mutant U2-2 being expressed in patient blood samples, we found no evidence of missplicing. Our findings cement the role of major spliceosomal snRNAs in the etiologies of neurodevelopmental disorders.

 

U4 snRNA遺伝子RNU4-2の変異は、最も一般的な単発性神経発達障害の1つを引き起こす Mutations in the U4 snRNA gene RNU4-2 cause one of the most prevalent monogenic neurodevelopmental disorders

Daniel Greene,Chantal Thys,Ian R. Berry,Joanna Jarvis,Els Ortibus,Andrew D. Mumford,Kathleen Freson & Ernest Turro
Nature Medicine  Published:31 May 2024
DOI:https://doi.org/10.1038/s41591-024-03085-5

Fig. 1

Abstract

Most people with intellectual disability (ID) do not receive a molecular diagnosis following genetic testing. To identify new etiologies of ID, we performed a genetic association analysis comparing the burden of rare variants in 41,132 noncoding genes between 5,529 unrelated cases and 46,401 unrelated controls. RNU4-2, which encodes U4 small nuclear RNA, a critical component of the spliceosome, was the most strongly associated gene. We implicated de novo variants among 47 cases in two regions of RNU4-2 in the etiology of a syndrome characterized by ID, microcephaly, short stature, hypotonia, seizures and motor delay. We replicated this finding in three collections, bringing the number of unrelated cases to 73. Analysis of national genomic diagnostic data showed RNU4-2 to be a more common etiological gene for neurodevelopmental abnormality than any previously reported autosomal gene. Our findings add to the growing evidence of spliceosome dysfunction in the etiologies of neurological disorders.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました